NFLX jumps on $82.7B deal walk, but P/E of 37 signals high growth expectations & competition risk.
Walmart's 4% margin is stable, but investors seek expansion for better returns. Higher-margin segments are key.
Omada Health (OMDA) boasts 53% sales growth & 6% margins at 3x sales. GLP-1 users see 28% more weight loss.
Target's 22% YTD gain beats market. Stock's cheap at 15x earnings, 3.8% dividend yield.
Anduril lands $20B Army deal! Revenue hit $2B last year, eyeing $60B valuation.
Dave Inc. director sells $6.4M shares amid strong earnings & low P/E. High beta, insider dump signals caution.
Jet fuel soars 75%+ on Mideast conflict, hitting airline valuations. Hedging offers some buffer.
Must Read